Startup profile for CoverCress: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

CoverCress funding, valuation and investors

Gene-edited winter oilseed (pennycress) crop for low-carbon fuel feedstock and cover-crop benefits.

Keep track of CoverCress

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Not publicly disclosed

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

Not publicly disclosed

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

acquired

Stage not recorded · St. Louis, MO

Source links not recorded Last verified: 2026-07-26

Overview

CoverCress Inc. (formerly Arvegenix) develops CoverCress™, a winter oilseed crop derived from field pennycress using breeding and gene editing. Farmers can grow it between corn and soybean seasons for revenue plus cover-crop ecosystem benefits; oil can feed renewable diesel and meal can go to animal feed. In August 2022 Bayer acquired a 65% majority ownership, with Bunge and Chevron U.S.A. retaining the remaining 35%. The company continues as a standalone entity headquartered in St. Louis. Early investors included Fulcrum Global Capital, Prelude Ventures, St. Louis Arch Angels, and others before the strategic control transaction.

Why CoverCress is interesting

St. Louis agtech exit signal: Bayer acquired a 65% majority stake (Aug 2022), with Bunge and Chevron retaining 35% — farm-to-fuel CoverCress™ winter oilseed commercialized from field pennycress.

Product & use cases

CoverCress™ seed and grain system enabling winter cash-crop production with oil for renewable fuels and meal for feed.

  • Corn-soy farmers adding a winter cash cover crop
  • Low carbon-intensity oil feedstock for renewable diesel
  • High-protein animal feed meal from processing

Key facts

  • Bayer acquired 65% majority stake (Aug 2022); Bunge and Chevron retain 35% (Bayer / BioSTL)
  • Winter oilseed from gene-edited field pennycress for renewable fuel + cover-crop benefits
  • Founded 2013 as Arvegenix by Monsanto alumni; St. Louis HQ
  • Operates as standalone entity post majority acquisition

Funding history (newest first)

Majority acquisition (Bayer 65%)

2022-08
  • Bayer (lead)
  • Bunge (participant)
  • Chevron U.S.A. (participant)

Source: https://www.bayer.com/media/en-us/bayer-expands-existing-investment-to-acquire-majority-share-in-sustainable-lower-carbon-oilseed-producer-covercress-inc/

Competitive landscape

Edge: Strategic ownership across Bayer (seed/traits), Bunge (crush), and Chevron (fuel) supply chain.

  • Camelina / other winter oilseeds direct

    Alternative intermediate oilseed crops.

  • Soy/used cooking oil feedstock incumbent

    Dominant renewable diesel feedstocks.

  • Traditional cover crops (no grain revenue) alternative

    Ecosystem benefits without cash grain.

Notable stories

  • BioSTL noted the Bayer control acquisition as a successful exit for venture, angel, and economic-development investors while CCI continues operating independently.

Industries

Climate Tech Biotech & Life Sciences

Related funding articles

Venture Capital Tracker pieces that cover CoverCress's financing or category context.

FAQs about CoverCress

Practical answers founders, operators, and investors typically search for.

Develops a gene-edited winter oilseed crop (from pennycress) for renewable fuel feedstock and cover-crop benefits.
St. Louis, MO.
Bayer holds a 65% majority stake (Aug 2022); Bunge and Chevron retain 35%.
Majority-owned by Bayer; still operates as a standalone company.
stage other; status acquired (majority control transaction).
2013 (as Arvegenix).
Flagship plant-science commercialization story in the Bayer Crop Science corridor.
https://www.covercress.com

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.